Sanitary Licence Versus Sanitary Registration: Two Parallel Tracks
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
In Nicaragua, the sanitary licence (Licencia Sanitaria) and the sanitary registration (Registro Sanitario) are two independent tracks: the licence is granted to the business establishment, the registration to the product. The respective bases are Article 6 of Chapter 5 and Article 1 of Chapter 5 of NTON 24001:2023. The licence covers only the activities stated on the certificate, while the registration is granted according to risk classification and carries a unique and permanent registration number (Article 6 of Chapter 7). RA 0007/2025 gives each track its own procedure: the licence runs through pre-evaluation, evaluation and inspection (Annex I, Article 5, item j), and the registration through pre-evaluation, evaluation and first-import analysis authorization (item k).
2. Legal basis
The distinction between the two tracks rests on parallel provisions of the technical standard and on the two procedures approved in Annex I of RA 0007/2025. The key provisions are set out below.
| Level | Instrument | Provision | Key point |
| Technical standard | NTON 24001:2023, «Tecnología de la salud. Dispositivos médicos. Requisitos para el Registro Sanitario» (La Gaceta No. 192, 2024-10-21) | Chapter 5, Article 6 | Establishments engaged in manufacturing, importing and/or distributing devices must hold a valid sanitary licence and may only carry out the activities authorized by that licence |
| Technical standard | NTON 24001:2023 | Chapter 5, Article 1 | The importer or distributor must complete sanitary registration of products according to risk classification before devices enter the country |
| Technical standard | NTON 24001:2023 | Chapter 7, Article 6 | After evaluation is passed and approval granted, a registration certificate is issued and a unique and permanent number is assigned to the product |
| Administrative decision | Administrative Resolution No. 0007/2025 (in force from 2025-05-02) | Annex I, Article 5, items j and k | Licence stages: pre-evaluation, evaluation, inspection; registration stages: pre-evaluation, evaluation, first-import analysis authorization (where applicable) |
| Administrative decision | Administrative Resolution No. 0007/2025 (in force from 2025-05-02) | Annex I, Article 5, items a and e | Licence applications may be filed only by the regente sanitario of the establishment or a nominated regente; registration applications must be filed by a health-science professional holding a power of attorney approved by SAJ |
| Administrative decision | Administrative Resolution No. 0007/2025 (in force from 2025-05-02) | Annex I, Article 9, item 6 | After the inspection is passed, the DDM issues the licence within no more than 3 working days |
3. Expert insights
Insight 1: the two tracks target different objects. The licence attaches to the «establecimiento» — the business establishment — while the registration attaches to the «producto». An importer holding one licence can carry multiple product registrations; the reverse does not hold, and a product registration cannot substitute for the importer’s licence. The two certificates have different expiry dates and different competent-authority practices, yet both are preconditions of lawful operation.
Insight 2: the boundary of the licence is defined by what the certificate states. The words of Article 6 of Chapter 5 — «solo podrán desempeñar las actividades autorizadas por la misma» — are a hard limit, and operating beyond the stated scope falls under the refusal, suspension and cancellation grounds of Chapter 10. Before extending the product portfolio, companies should first verify the scope of activities stated on the licence, rather than first checking whether the product is registered.
Insight 3: the registration number is unique and permanent. Article 6 of Chapter 7 speaks of «un numero único y perpetuo». The number does not change on renewal or on post-registration changes; it is master data the company must maintain over the long term, and it is the index key for the 17 categories of post-registration changes and for renewal.
Insight 4: the two stages have different timeline structures, and the evaluation duration of the registration track is left open. The three licence stages are explicitly counted in RA 0007/2025 (pre-evaluation 5, evaluation 10, inspection 20, issuance 3 working days). For the registration track, the evaluation stage in Annex I, Article 12, item 1 refers to «el tiempo establecido en la normativa vigente» — the time set in the current regulatory framework — pointing back to NTON, while Chapter 7 of NTON only prescribes correction periods (15 and 20 working days) and does not prescribe the duration of evaluation itself. This is a timeline gap verified in this volume, and no estimate is offered on its behalf.
Insight 5: the two tracks may be handled by different natural persons. Item a of Annex I, Article 5 confines licence applications to the regente sanitario of the establishment or a nominated regente; item e confines registration applications to a health-science professional holding a power of attorney approved by SAJ. Both must hold SAJ-approved powers of attorney (Chapter 6 of NTON, items 4, 5 and 6), but the same person is not required.
Insight 6: the registration track has one end-stage step the licence track lacks. Item k of Annex I, Article 5 lists the first-import analysis authorization as the third stage of registration; nothing equivalent exists in the licence track. Issuance of the registration certificate does not mean the product can be sold — the first-import quality check and the release letter must still come (Article 8 of Chapter 7 and Article 14 of Annex I). Conflating the end points of the two tracks is a common cause of misjudging when a product becomes sellable.
4. Practical recommendations
- Manage the two certificates separately: keep a ledger pairing the establishment licence with the establishment and another pairing product registrations with products, recording expiry dates and renewal windows for each.
- Before extending the portfolio, verify the scope of activities stated on the licence; where the scope falls short, complete a licence change first and only then start the product registration.
- Build the product archive around the registration number as master data: the number is unique and permanent, and both renewal and changes attach to the same number.
- Do not apply the licence track’s explicit timelines to the registration track: the evaluation duration is not stated in the current texts, so schedule operational milestones backwards from the correction windows (15 and 20 working days).
- Clarify the division of labour between the regente and the registrador: the two roles may be held by different natural persons, but both require SAJ-approved powers of attorney.
- Compute the sellable date from three steps — issuance of the registration certificate, a passed first-import quality check, and the release letter — and never use the certificate issuance date as the start of sales.
5. Verification checklist
- □ Established separate ledgers for the establishment licence and the product registrations, with expiry dates and renewal windows recorded
- □ Verified the scope of activities stated on the sanitary licence and confirmed the intended portfolio falls within it
- □ Built the product archive indexed by the unique and permanent registration number (Chapter 7, Article 6)
- □ Handled registration scheduling on the basis that the evaluation duration is not explicitly stated, using the correction windows as anchors
- □ Clarified the division of labour between the regente sanitario and the registrador, with both powers of attorney approved by SAJ
- □ Computed the sellable date from the three steps, without using the certificate issuance date as the start of sales
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us